RxDoctor Payments Data

Jamie McGovern

Rye, NYNPI 1306552674

Payments from drug & device makers

$3,437in general payments, 2019–2025

Across 144 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dermavant Sciences, Inc.$823
  • Regeneron Healthcare Solutions, Inc.$624
  • E.r. Squibb & Sons, L.L.C.$559
  • Arcutis Biotherapeutics, Inc.$433
  • Sanofi$244
  • Amgen$145
  • plus $610 from 11 others

What the payments were for

  • Food & beverage$3,35698%
  • Education$812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate45$4,124
Tacrolimus23$2,845
Ammonium Lactate106$2,036
Ketoconazole110$1,654
Azelaic Acid12$1,010
Metronidazole24$797
Triamcinolone Acetonide52$458
Mupirocin48$344
Doxycycline Hyclate11$318
NystopNystatin16$292
Hydrocortisone40$229
Mometasone Furoate11$169
Nystatin16$169

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →